Skip to content

SciLife Consulting

Active
Private limited companyfounded 2019active for 7 yearsWaterstraat 9A, 3071 Kortenberg, BelgiumKBO/BCE: BE 0732.585.174

From the official registers: KBO 6 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

SciLife Consulting has been active since 2019 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €127,331 and a net result of €47,622. Equity has been growing by about 13% per year since 2020. Its solvency ranks better than 53% of 615 sector peers (NACE 72, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

KBO
Status
Active since 13-08-2019 Normal situation
Legal form
Private limited company
Registered office
Waterstraat 9A, 3071 Kortenberg
Activity
Research and development on biotechnology NACE 72101and 4 others
Establishment unit
2.292.070.507 3071 Kortenberg, since 13-08-2019
Financial year end
30 September
Peppol
Reachable since 26-07-2024

Board and ownership

Board
  • Cluckers LiesbethDirector · since 13-08-2019

Financial position

95 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts to 30-09-2025
Gross margin
€77,658
▼ 21.1%
Turnover
≈ €230,000
estimated
Profit
€47,622
▼ 26.0%
Equity
€127,331
▼ 8.2%
Total assets
€198,474
▼ 9.4%
Staff
≈ 0.1 FTE
estimated
2025 accounts filed 30 days before the deadline
Filed on 31-03-2026PDF
Score breakdownlowers riskLiquidity: current ratio 2.32, cash €83,814Sector: Scientific research and development (NACE 72)Equity €127,331 (64.2% of total assets)Size: total assets €198,474Show the evidence

Checked score

Score 2025
95 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 61% of micro companies in research and development (NACE 72)
Financial strength · tick: 2024
Strong
Solvency 89+1
equity 64.2% of total assets
Liquidity 84+1
short-term debt 35.1% · cash 42.2%
Profitability 99-1
return on assets 24.0%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.1% (935 companies, NACE 72, micro)
Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: 0.1%▲ +0.1 percentage points vs 12-2024 02-2025: 0.1%● unchanged vs 01-2025 03-2025: 0.1%● unchanged vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025highest value 05-2025: < 0.1%▼ -0.1 percentage points vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025lowest value 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: 0.1%▲ +0.1 percentage points vs 03-2026 05-2026: < 0.1%▼ -0.1 percentage points vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026
Credit of up to €12,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 2.32 (2.2 in 2024), above the usual 1.5. Short-term debt is 35.1% and cash 42.2% of total assets. 35.8% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 72, micro). It does better than 56% of them on solvency, 73% on liquidity, 80% on profitability and 35% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskneutral
lowers risk · Liquidity: current ratio 2.32, cash €83,814
NBB · annual accounts
lowers risk · Sector: Scientific research and development (NACE 72)
KBO
lowers risk · Equity €127,331 (64.2% of total assets)
NBB · annual accounts
lowers risk · Size: total assets €198,474
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 30-09-2025 was due by 30-04-2026 and was filed on 31-03-2026, 30 days ahead of the deadline.
NBB · 6 filings
Deviation from the deadline
2025
30 days early
2024
30 days early
2023
30 days early
2022
1 day early
2021
30 days early
2020
30 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 6 accounts on average 25 days before the deadline. In the sector (NACE 72), the median for financial year 2024 was 13 days before the deadline, and 32% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The financial year that closed on 30-09-2026 is due by 30-04-2027. Nothing is late today. The company usually files around 31 March (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
30-09-2026 year end01-11-2026 today30-04-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: Always filed on timeaccounts within the deadline every year 6 years View
  • Positive: 6 profitable years in a rowprofit 2025: €47,622 6 years View

Documents

Annual accounts at the NBB

All 6 annual accounts

Acts in the Belgian Official Gazette

All publications in the Belgian Official Gazette

Articles and registers

Key facts about SciLife Consulting

What is the company number of SciLife Consulting?
The company number of SciLife Consulting is 0732.585.174. The VAT number is the same number with BE in front: BE 0732.585.174.
Where is SciLife Consulting based?
The registered office is at Waterstraat 9A, 3071 Kortenberg.Company details
What does SciLife Consulting do?
According to the KBO register, the main activity is research and development on biotechnology (NACE 72101).
What is the legal form of SciLife Consulting?
The legal form of SciLife Consulting is Private limited company (BV).
When was SciLife Consulting founded?
SciLife Consulting was founded on 13-08-2019.
Is SciLife Consulting still active?
Yes, SciLife Consulting is an active enterprise in the KBO register.
What is the turnover of SciLife Consulting?
The turnover in financial year 2025 is ≈ €230,000. This figure is estimated from the gross margin of €77,658 and 2,678 comparable companies of the same size. It probably lies between €150,000 and €400,000. It is a rough estimate.Financials
Is SciLife Consulting profitable?
In financial year 2025, SciLife Consulting made a profit of €47,622.
Where can I find the annual accounts of SciLife Consulting?
SciLife Consulting filed 6 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts 2025 (PDF)
When are the next annual accounts of SciLife Consulting due?
SciLife Consulting must file the annual accounts for financial year 2026 by 30-04-2027.Timeline

Comparable companies

These companies have the same main activity as SciLife Consulting: research and development on biotechnology (NACE 72101). They are comparable in size and age: total assets between €139,000 and €379,000, founded between 2019 and 2021.

CompanyTotal assetsGross margin
SciLife Consulting Kortenberg€198,474€77,658
HU-MENTIS Walcourt€163,664€63,102
OPERO Grimbergen€225,981€168,579
Vertommen Johan Holsbeek€369,058€105,701
BVU CONSULTING Grimbergen€378,924€64,479
LP ENGINEERING Liège€138,903€53,690
MDC Kestens Lille€140,827€60,103
Full comparison

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.